---
created: 2025-04-13
updated: 2025-04-13T10:53
id: q}o:2*H`:r
specialty: ortho
specialty_id: 83
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies
  - "source/ak-step1-v11:": 
  - theme/firstaid::02-immunology::04-immunosuppressants::04-therapeutic-antibodies::canakinumab
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::07-immunology
  - "source/ak-step1-v11:": 
  - theme/pixorize::01-immunology::05-cytokines::02-il-1
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::miscellaneous-pharm
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::4-loweryield
  - source/ak-step1-v11::^systems::musculoskeletal::pharmacology"
type: flashcard
---

# Question
Periodic Fever Syndromes can be treated with **Canakinumab**

---

# Answer
These are a group of disorders that have unregulated production of IL-1B for one reason or the other (typically due to disruption of the Inflammasome)  Ex. Muckle-Wells (aka CAPS; sensorineural deafness, chills and hives, amyloidosis - caused by a defect in the inflammasome pattern recognition receptor Cryopyrin)